What's new for 'childhood cancer' in PubMed
15 Outubro 2011
This message contains My NCBI what's new results from the National Center for BiotechnologySender's message:
Sent on Saturday, 2011 Oct 15
Search cancer
Limits:Randomized Controlled Trial, All Child: 0-18 years
| PubMed Results |
| 1. | A randomized controlled trial of propranolol for infantile hemangiomas. |
| Hogeling M, Adams S, Wargon O. | |
| Pediatrics. 2011 Aug;128(2):e259-66. Epub 2011 Jul 25. | |
| PMID: 21788220 [PubMed - indexed for MEDLINE] RCT demonstrated propranolol effect in hemangiomas of infancy. Now cleared as first choice? |
| 2. | Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia. |
| Lange BJ, Yang RK, Gan J, Hank JA, Sievers EL, Alonzo TA, Gerbing RB, Sondel PM. | |
| Pediatr Blood Cancer. 2011 Sep;57(3):398-405. doi: 10.1002/pbc.22966. Epub 2011 Jun 16. | |
| PMID: 21681921 [PubMed - indexed for MEDLINE] Unfortunately, this large immunotherapy trial in pediatric AML did not show effect of IL-2 in disease free survival or overall survival. |